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The prognostic power of myocardial perfusion imaging in pa-
tients with ischemic heart disease (IHD) has been demonstrated
since planar imaging. We aimed to investigate whether gated
SPECT retains this value in current cardiology if compared with
a complete diagnostic work-up and with more recent prognostic
indicators.Methods:We selected from our database a cohort of
676 consecutive inpatients who underwent a complete diagnos-
tic work-up that included gated SPECT and coronary arteriogra-
phy for known or suspected IHD. Patients with acute myocardial
infarction (MI), previous coronary artery bypass surgery, or overt
hyperthyroidism and patients who were undergoing dialysis
treatment were excluded. During follow-up (median, 37 mo), 24
patients died from cardiac causes and 19 experienced a nonfatal
MI. Results: The following were determined to be independent
predictors of event-free survival (cardiac death and nonfatal
MI) in the different phases of diagnostic work-up using Cox pro-
portional hazards regression analysis: among clinical variables, a
previous MI; among laboratory examinations, serum creatinine
and low-density lipoprotein (LDL) and high-density lipoprotein
(HDL) cholesterol levels; among electrocardiographic and echo-
cardiographic variables, left ventricular ejection fraction; and
among SPECT variables, summed rest score (SRS) and summed
difference score (SDS). In addition, a score of coronary stenoses
at angiography was an independent predictor. When the above
predictors were tested together, SRS (P , 0.0001), SDS (P 5
0.0108), and serum creatinine (P 5 0.0186) and LDL and HDL
cholesterol levels (P 5 0.0222) were the final independent pre-
dictors of event-free survival. When gated SPECT was added
to the clinical, laboratory, electrocardiographic, and echocardio-
graphic variables, the prognostic stratification significantly im-
proved (P , 0.05); when coronary arteriography was added to
gated SPECT, prognostic stratification did not further improve
(P . 0.25). If the information provided by gated SPECT was
made available after clinical, laboratory, electrocardiographic,
echocardiographic, and angiographic variables, the prognostic
stratification still improved significantly (P, 0.05). In 492 of these
patients with ascertained IHD, SRS and SDS were the final inde-
pendent predictors of survival. Medical treatment and coronary
revascularization did not affect the prognostic information of
gated SPECT. Conclusion: Myocardial perfusion abnormalities
at rest and after stress are still the best predictors of cardiac
event–free survival in patients with known or suspected IHD,
even when compared with an extensive diagnostic work-up.
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The prognostic value of stress testing with myocardial
perfusion imaging has been established since the initial
studies with 201Tl, in which extent and severity of myocardial
hypoperfusion were shown to be independent predictors of
prognosis in patients with known or suspected ischemic heart
disease (IHD) (1–3). In addition, thallium imaging, com-
pared with clinical and exercise stress test data, provided
further prognostic information, and the combination of the
above variables provided more prognostic information than
did the combination of clinical and angiographic data (4,5).
However, substantial changes in nuclear cardiology have
taken place over the past 2 decades, leading to improved
techniques. Thus, SPECT has replaced planar imaging
(6,7), and technetium-based imaging agents have been
largely used as an alternative to 201Tl (8). The addition of
gating to myocardial perfusion imaging has further im-
proved diagnostic accuracy (9) and quantitative analysis of
digital data (10). Meanwhile, the prognostic power of
2-dimensional echocardiography in IHD patients has been
demonstrated both at rest and after stress (11,12). Further-
more, several laboratory examinations were shown to
stratify the risk of cardiac patients; these variables included
serum creatinine (13), triiodothyronine levels and indica-
tors of a mild thyroid dysfunction (14), serum cholesterol
and its fractions (15), C-reactive protein (16), and cardiac
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peptides (17). In parallel, great changes have also taken
place in clinical cardiology, including secondary preven-
tion, improved medical treatment, percutaneous coronary
interventions, and surgical procedures. Because of these
interventions, the clinical profile of patients with IHD has
changed, and commonly treated patients are now older and
affected by greater comorbidity than in the past (18).
With these considerations in mind, we sought to inves-
tigate whether gated SPECT with technetium-based imag-
ing agents still preserves its prognostic value in current
cardiology when compared with a complete diagnostic
work-up and with more recent prognostic indicators.
MATERIALS AND METHODS
Patients
Starting in 2000, we adopted a fully computerized clinical
report that allowed handling and recording of the clinical and
administrative data of all patients admitted. From this database,
we retrospectively selected a group of consecutive patients ad-
mitted for known or suspected IHD who had undergone a
complete diagnostic work-up that included stress/rest myocardial
perfusion imaging and coronary arteriography. Patients with acute
or recent ST segment elevation myocardial infarction (MI),
previous coronary artery bypass graft surgery, chronic renal failure
under dialysis treatment, or primary overt hyperthyroidism (free
triiodothyronine level . 420 pg/dL or free thyroxine level . 1.85
ng/dL, with an undetectable thyrotropin level) were excluded from
the study. Thus, a study cohort of 676 patients was selected;
patient characteristics are shown in Tables 1 and 2.
At hospital discharge, 492 of these patients (73%) were affected
by IHD. In 479 patients, the diagnosis was based on the angio-
graphic evidence of coronary stenoses in at least 1 of the major
coronary arteries or secondary branches. In 13 patients with
normal coronary arteries, the diagnosis was based on the evidence
of a previous MI (documented by clinical records, 8 patients) or
on the recording of electrocardiographic patterns of Prinzmetal
angina (collected during hospitalization, 5 patients). The 184
patients with normal coronary arteries in whom the suspicion of
IHD was not confirmed were affected by dilated cardiomyopathy
or myocarditis (60 patients), syndrome X (77 patients), or valvular
heart disease (8 patients). The remaining 39 subjects were unaf-
fected by disease.
Diagnostic Work-up
The diagnostic work-up included clinical evaluation, laboratory
tests, 12-lead electrocardiography (ECG), 2-dimensional echocar-
diography, stress/rest gated SPECT, and coronary arteriography.
Gated SPECT was performed before coronary arteriography in
623 patients (92%) and after arteriography in the remaining
53 patients (8%). The time interval between gated SPECT and
coronary angiography was 11 6 4 d (range, 1–19 d). Patients
experiencing cardiac events during this time were excluded from
the study.
Clinical Examination. The clinical variables explored were
patient age, sex, and history of angina (at rest, on effort, or mixed);
previous MI; and cardiovascular risk factors. The latter included
having a family history of premature IHD (before age 55 y if male,
65 y if female), diabetes mellitus (fasting glucose levels $ 126
mg/dL on 2 occasions or need for oral hypoglycemic or insulin
agents) (19), arterial hypertension (systolic blood pressure $ 140
mm Hg, diastolic blood pressure . 90 mm Hg, or use of an
antihypertensive drug) (20), hypercholesterolemia (total choles-
terol $ 200 mg/dL or use of a lipid-lowering drug) (21), hyper-
triglyceridemia (triglycerides $ 150 mg/dL), and obesity (body
mass index $ 30 kg/m2) (22) and being a current or former
smoker (within the last year).
Laboratory Examinations. The laboratory variables explored
were erythrocyte sedimentation rate; fasting glucose, serum cre-
atinine, total cholesterol, and high-density lipoprotein (HDL) and
low-density lipoprotein (LDL) cholesterol levels; triglycerides;
lipoprotein (a); thyrotropin; free triiodothyronine; free thyroxine;
C-reactive protein; and fibrinogen.
TABLE 1. Clinical Characteristics of Patients (n 5 676)
Characteristic Finding
Age (y) 65 6 10
Men 543 (80%)
Angina on effort 172 (25%)
Angina at rest 136 (20%)
Mixed angina 149 (22%)
Previous infarction 290 (43%)
Family history of premature IHD 350 (52%)
Diabetes mellitus 183 (27%)
Arterial hypertension 391 (58%)
Hypercholesterolemia 441 (65%)
Hypertriglyceridemia 169 (25%)
Obesity 209 (31%)
Smoker within last year 345 (51%)
LVEF (%) 50 6 13
Data are numbers of patients, with percentages in parenthe-
ses, or mean 6 SD.
TABLE 2. Angiographic and Scintigraphic
Characteristics of Patients (n 5 676)
Characteristic Finding
Single-vessel coronary artery disease 181 (27%)
Double-vessel coronary artery disease 148 (22%)
Triple-vessel coronary artery disease 74 (11%)
Left main stenosis 36 (5%)
Stenoses in secondary branches 40 (6%)
No significant stenoses 197 (29%)
SSS 9.1 6 4.2
SDS 5.2 6 3.8
SRS 2.2 6 2.7
Baseline LVEF (%) 50 6 14
Baseline end-diastolic volume (mL) 114 6 25
Baseline end-systolic volume (mL) 65 6 22
Baseline summed motion score 8 6 6
Baseline summed thickening score 6 6 5
Poststress LVEF (%) 49 6 16
Poststress end-diastolic volume (mL) 125 6 18
Poststress end-systolic volume (mL) 69 6 17
Poststress summed motion score 9 6 7
Poststress summed thickening score 7 6 6
Data are numbers of patients, with percentages in parenthe-
ses, or mean 6 SD.
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Electrocardiographic Data. The electrocardiographic variables
examined were 12-lead ECG results (normal or abnormal), bicycle
exercise stress test results (negative or positive, if ST segment
depression $ 0.15 mV), having undergone or not the exercise
stress test, and maximal workload on effort (watts).
Echocardiographic Data. Two-dimensional echocardiographic
variables were left ventricular ejection fraction (LVEF), left
ventricular (LV) end-diastolic diameter, wall motion score index,
and end-diastolic thickness of the interventricular septum and
posterior wall. LVEF was measured by the single-plane Simpson
rule; in the case of geometrically distorted ventricles or LV
regional wall motion abnormalities, the EF was measured by the
biplane Simpson rule.
Gated SPECT. Gated SPECT was performed with a double-
head g-camera (E. Cam; Siemens Medical Solutions, and Millen-
nium MC; GE Healthcare) equipped with a high-resolution col-
limator. A protocol consisting of a 64 · 64 matrix, 32 projections
per head, 40-s projections, and 8 frames per cycle was applied,
with appropriate energy photopeaks. All studies were recon-
structed using a 2-dimensional Butterworth filter, with an order
of 2.5 (99mTc-tetrofosmin) and a cutoff frequency of 0.3 cycles per
pixel (99mTc); projections were reconstructed into transaxial
images using filtered backprojection with a ramp filter. No
attenuation or scatter correction was used.
Each patient underwent stress/rest gated SPECT according to a
single-day protocol. A total of 539 patients (80%) underwent
exercise stress testing, and 137 patients (20%) underwent a
dipyridamole stress test. Bicycle exercise stress tests (stepwise
increments of 25 W every 2 min) or dipyridamole stress tests (0.56
mg/kg intravenously over 4 min) were chosen on the basis of the
patient’s ability to exercise and after evaluation of medical
treatment. Of the 539 patients submitted to exercise stress testing,
387 reached 85% of the maximal predicted heart rate, 58 reached
from 80% to 85% of the maximal predicted heart rate, and the
remaining 94 patients did not reach the target heart rate and were
injected for significant ST segment depression (69 patients) or
ventricular arrhythmias (25 patients). In every patient, standard
protocols for the injection of 99mTc-tetrofosmin (370 MBq for
stress imaging and 740 MBq for rest imaging) were used both
during stress and at rest. Images were acquired from 15 to 45 min
after the stress and from 30 to 45 min after the rest injections. All
patients with previous MI were subjected to baseline tracer
injection after sublingual administration of nitrates. Adverse
events were defined according to international guidelines.
LV regional wall motion and thickening were quantitatively
analyzed at rest and after stress using a previously validated
software program (Quantitative Gated SPECT; Cedars Sinai) that
provided scores of regional wall motion (0, normal; 5, dyskinetic)
and thickening (0, normal; 3, absent thickening) according to a 17-
segment polar map (23). In every patient, Quantitative Gated
SPECT and Quantitative Perfusion SPECT programs were used
both at rest and after stress after qualitative analysis of recon-
structed images. In 6% of patients (mainly those with low EF and
dominance of myocardial necrosis), LV contours were manually
adjusted. By adding the 17-segment scores, summed stress scores
(SSS) and summed rest scores (SRS) were automatically calcu-
lated. The summed difference score (SDS), indicating the extent
of reversible perfusion defects, was obtained by calculating the
differences between the SSS and the SRS (24). Regional wall
motion analysis by Quantitative Perfusion SPECT was used to
identify attenuation artifacts in patients with fixed positive defects
at rest and after stress. The variables derived from gated SPECT were
LVEF, summed motion, and thickening scores at rest; LVEF, summed
motion, and thickening scores after stress; and SRS, SSS, and SDS.
Coronary Arteriography. Angiographic images (Judkins tech-
nique) were qualitatively analyzed. The variables explored were
the presence of a stenosis (.50% luminal diameter reduction) in
the main coronary arteries and a semiquantitative score of the
extent of coronary lesions. To derive this score, the location of
coronary stenoses was categorized as proximal, middle, or distal
for left anterior descending artery and as proximal or distal for left
circumflex and right coronary arteries. If a vessel presented more
than 1 stenosis, only the most severe was considered; eventual
downstream lesions were ignored. A score was assigned to each
stenosis on the basis of the extent of the perfusion territory
according to a 17-segment model (25). Specifically, scores of 7, 5,
and 3 were assigned to proximal, middle, and distal left anterior
descending artery stenoses, and scores of 5 and 3 were assigned to
proximal and distal left circumflex and right coronary artery
stenoses. A score of 12 was assigned to left main stenoses; in this
case, left anterior descending or left circumflex stenoses were
ignored. The final score (ranging from 0 to 17) was obtained by
summation. The same score was also obtained using a 70%
coronary stenosis threshold.
Follow-up
Patients were followed up by periodic examinations in the
outpatient setting. In patients who did not attend this program,
follow-up data were obtained using written telephone interview
(administered to the patient or the patient’s family by dedicated
personnel) or mail questionnaires. In case of negative answers, the
local demographic registry was queried. Cardiac death was defined
as death caused by acute MI, death caused by heart failure, or a
sudden and unexpected death not related to any possible cause;
nonfatal MI was documented by clinical records. The study protocol
was approved by the local committee on human research. In
addition, patients gave written informed consent to have their
clinical data prospectively collected for research purposes.
Statistical Analysis
Continuous variables were expressed as mean 6 SD, and
categoric variables were expressed as percentages. The primary
endpoint was the occurrence of cardiac events, defined as cardiac
death or nonfatal acute MI. Predictors of survival were initially
identified by univariate analysis performed using the Cox pro-
portional hazards regression model. Categoric variables were
included in the model as dummy variables. The independent
predictors of survival at each of the different stages of diagnostic
work-up were identified using multivariate Cox regression anal-
ysis and included all the variables collected at that stage. A
backward elimination procedure was used to select the indepen-
dent variables, that is, those variables resulting in a significant
outcome. Once the independent predictors of survival at the
different steps of the diagnostic work-up were identified, these
predictors were entered into a Cox proportional hazards regression
analysis to obtain the final independent predictors of cardiac
event–free survival. The incremental prognostic information
obtained at each step of the diagnostic process was evaluated by
the x2 improvement.
To assess the prognostic value of the Cox proportional hazards
regression models, we used the time-dependent receiver-operat-
ing-characteristic (ROC) curve estimation from censored survival
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data using the nearest-neighbor estimation method (26). The linear
prognostic scores obtained from the final Cox models were
considered in the analysis. The area under the time-dependent
ROC curves (AUC) was used to express the prognostic accuracy
of the final Cox models. All statistical tests were 2-tailed; a P
value of less than 0.05 was considered significant. Statistical
analysis was performed with free and commercially available
software (JMP 4.0 [SAS Institute Inc.]; SPSS 10.0 [SPSS Inc.]; R:
A Programming Environment for Data Analysis and Graphics,
version 2.7.1 [R Foundation for Statistical Computing]; and
STATA [StataCorp LP]).
RESULTS
During follow-up (median, 37 mo), 59 of 676 patients
died (24 from cardiac causes) and 19 experienced a non-
fatal MI. A plot of cardiac event–free survival (cardiac
death and nonfatal MI) is shown in Figure 1. The annual
all-cause mortality rate was 2.4%, and the annual rate of
cardiac events was 1.7%.
Predictors of Cardiac Event–Free Survival
As shown in Table 3, several variables were significant
predictors of cardiac event–free survival at univariate
analysis. Multivariate Cox regression analysis determined
that the following variables were independent predictors at
the different stages of diagnostic work-up: among clinical
data, a previous MI; among laboratory tests, serum creat-
FIGURE 1. Event-free survival (cardiac death and nonfatal
MI) in patients with known or suspected IHD.
TABLE 3. Significant Predictors of Event-Free Survival Using Univariate Analysis
Variable HR 95% CI x2 P
Clinical evaluation
Previous MI 2.99 1.56–5.95 12.10 0.0005
Laboratory examination
Creatinine level 3.34 1.78–5.72 12.11 0.0005
HDL cholesterol level 0.96 0.93–0.99 5.07 0.0244
ECG
Abnormal 12-lead findings 3.85 1.18–23.63 5.31 0.0212
Stress test not performed 2.23 1.22–4.14 6.82 0.0090
Maximal workload on effort 0.98 0.97–0.99 4.22 0.0399
Echocardiography
LVEF 0.95 0.93–0.97 24.04 ,0.0001
LV end-diastolic diameter 1.07 1.03–1.11 12.85 0.0003
Wall motion score index 3.24 1.87–5.57 16.87 ,0.0001
Gated SPECT
LV end-diastolic volume at rest 1.01 1.00–1.01 18.35 ,0.0001
LV end-systolic volume at rest 1.01 1.01–1.02 20.40 ,0.0001
LVEF at rest 0.95 0.93–0.97 24.28 ,0.0001
Summed motion score at rest 1.03 1.01–1.05 8.45 0.0037
Summed thickening score at rest 1.06 1.03–1.08 16.18 ,0.0001
SRS 1.16 1.10–1.21 27.11 ,0.0001
LV end-diastolic volume after stress 1.01 1.00–1.01 19.49 ,0.0001
LV end-systolic volume after stress 1.01 1.00–1.01 22.79 ,0.0001
LVEF after stress 0.95 0.93–0.97 23.67 ,0.0001
Summed motion score after stress 1.03 1.01–1.05 9.96 0.0016
Summed thickening score after stress 1.05 1.03–1.07 16.14 ,0.0001
SSS 1.21 1.14–1.28 38.25 ,0.0001
SDS 1.25 1.11–1.31 25.47 ,0.0001
Coronary arteriography
LAD stenosis 1.83 1.01–3.44 3.90 0.0482
RCA stenosis 2.14 1.17–3.98 6.15 0.0131
Score of coronary stenoses (50% stenosis threshold) 1.08 1.02–1.14 7.34 0.0067
Score of coronary stenoses (70% stenosis threshold) 1.05 1.00–1.11 3.49 0.0616
LAD 5 left anterior descending coronary artery; RCA 5 right coronary artery.
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inine and the ratio between LDL and HDL cholesterol
levels; among electrocardiographic and echocardiographic
variables, LVEF; among the variables extracted from gated
SPECT, SRS and SDS; and among angiographic variables,
the score of the extent of coronary stenoses (Table 4). When
all the above predictors were evaluated together (Table 5),
only SRS and SDS, serum creatinine, and LDL/HDL
cholesterol levels were (in descending order of signifi-
cance) the final independent predictors of cardiac event–
free survival (global x2 5 38.84, P , 0.0001). An SRS
value greater than or equal to 4 identified patients at risk of
cardiac events, with a sensitivity of 48% and a specificity of
70%. An SDS value greater than or equal to 6 identified
patients at risk, with a sensitivity of 48% and a specificity
of 75%.
In the 492 patients in whom the diagnosis of IHD was
ascertained, SRS (hazard ratio [HR], 1.20; 95% confidence
interval [CI], 1.12–1.28; x2 5 26.67; P , 0.0001) and SDS
(HR, 1.15; 95% CI, 1.04–1.28; x2 5 7.30; P 5 0.0069)
were the only final independent predictors of survival
(global x2 5 27.72, P , 0.0001). The AUC showed a
good prognostic value for the 2 final Cox models (AUC 5
0.75 for total patients [95% CI, 0.68–0.82] and AUC 5
0.73 for patient with ascertained IHD [95% CI, 0.65–0.82]).
Incremental Prognostic Value
Figure 2 demonstrates that the prognostic information
significantly increased, adding to the clinical variables those
extracted from laboratory tests, 12-lead ECG, echocardiog-
raphy, and gated SPECT in hierarchical order. The selected
variables were those that were independent predictors of
event-free survival at the different stages of diagnostic work-
up. Once the above variables were considered, coronary
arteriography did not add any significant prognostic infor-
mation. Conversely, if the information provided by coronary
arteriography was made available after ECG and echocardi-
ography, gated SPECT still significantly improved the prog-
nostic information (Fig. 3).
Effect of Treatment
Of the 492 patients with ascertained IHD, 187 were
treated medically and 305 were revascularized (180 by
percutaneous coronary interventions, 110 by coronary ar-
tery bypass graft surgery, and 15 by both). Medically
treated patients had less extensive IHD than those who
were revascularized. Specifically, medically managed pa-
tients had lower values of SDS (4.9 6 3.5 vs. 5.7 6 2.9,
P 5 0.0001), a lower number of coronary stenotic vessels
(0.7 6 1.0 vs. 1.9 6 0.9, P 5 0.0005), and a lower score of
coronary stenoses (6.0 6 4.8 vs. 8.7 6 4.2, P , 0.0001)
than did revascularized patients. Cardiac events occurred in
12 medically managed and in 25 revascularized patients. At
multivariate Cox regression analysis, the type of treatment
(P 5 0.485) did not affect the ability of gated SPECT
(SRS: HR, 1.20; 95% CI, 1.12–1.28; P 5 0.000; and SDS:
HR, 1.15; 95% CI, 1.04–1.27; P 5 0.008) to predict event-
free patient survival.
A total of 256 patients were revascularized within 60 d of
nuclear testing (165 by percutaneous coronary interven-
tions, 84 by coronary artery bypass graft surgery, and 7 by
both) and 49 subsequently. Censoring of the patients at the
time of revascularization cardiac events occurred in 12
patients, and SRS was the only final independent predictor
of cardiac event–free survival (HR, 1.24; 95% CI, 1.12–
1.37; P 5 0.0006).
TABLE 4. Independent Predictors of Event-Free Survival
Using Multivariate Analysis at Each Stage of
Diagnostic Work-up
Variable HR 95% CI x2 P
Clinical evaluation
Previous MI 2.99 1.59–5.95 12.09 0.0005
Laboratory examination
Creatinine level 3.24 1.60–5.85 9.57 0.0020
LDL/HDL cholesterol
level
1.42 1.01–1.95 3.99 0.0456
ECG and echocardiography
LVEF 0.95 0.93–0.97 24.04 ,0.0001
Gated SPECT
SRS 1.21 1.14–1.28 35.68 ,0.0001
SDS 1.18 1.07–1.29 11.37 0.0007
Coronary arteriography
Score of coronary
stenoses
1.08 1.02–1.14 7.34 0.0067
TABLE 5. Final, Independent Predictors of Event-Free
Survival Using Multivariate Analysis, Considering
All Stages of Diagnostic Work-up
Variable HR 95% CI x2 P
SRS 1.16 1.08–1.25 16.43 0.0001
SDS 1.15 1.03–1.27 6.50 0.0108
Creatinine level 2.51 1.18–4.79 5.54 0.0186
LDL/HDL cholesterol level 1.53 1.06–2.16 5.23 0.0222
FIGURE 2. Incremental prognostic value during diagnostic
work-up. Information provided by stress/rest gated SPECT
is available after clinical examination, laboratory tests, and
ECG and echocardiography but before coronary arteriogra-
phy.
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DISCUSSION
This study shows that myocardial perfusion abnormali-
ties obtained after stress and the extent of scar tissue
detected by gated SPECT are the best predictors of cardiac
events in patients with suspected or ascertained IHD. The
ability of nuclear cardiology to predict the outcome of
patients with IHD has been well known for several years
(1–7,10). In respect to these pivotal and to more recent
studies (27–29), we compared gated SPECT data with those
obtained during the diagnostic work-up (13–17). Although
several variables were able to predict cardiac event–free
survival, myocardial perfusion abnormalities remained the
best predictor of patient outcome when all the different
stages of the diagnostic process were considered, including
coronary arteriography.
Gated SPECT and LVEF
Since the initial study performed using gated blood-pool
scintigraphy (30) in post-MI patients, LVEF has been
acknowledged to be a powerful predictor of mortality in
patients with IHD. The prognostic impact of LVEF has
been widely confirmed in large multicenter studies (11,31).
Furthermore, the prognostic impact of LVEF has been
extended to a wide variety of patients, including those with
heart failure, cardiomyopathies, and valvular heart disease
(32). Thus, the value of LVEF has become one of the main
determinants of therapeutic decision making, as in the case
of implantable cardioverter defibrillators or cardiac re-
synchronization therapy (33). In the present study, when
the prognostic power of LVEF at rest was compared with
that of scar-tissue extent, the power of LVEF disappeared.
This observation is not surprising, because LVEF repre-
sents a global normalized ratio and is susceptible to
changes in preload and afterload and contractility. On the
other side, SRS is an index of normalized uptake, coupled
to viable or scarred segments and normalized to control
subjects, and is independent of hemodynamic changes,
myocardial contractility, and medical treatment. The supe-
riority of perfusion imaging in prognostic stratification
might suggest a superiority in guiding decision making;
however, this hypothesis should be addressed in specific
prospective studies.
In a previous study, poststress EF and end-systolic LV
volumes were shown to have incremental prognostic values
over prescan and perfusion information (34). Subsequently,
poststress EF was the strongest predictor of mortality,
whereas the SDS was the strongest predictor of MI (35).
The divergence with these studies could be explained by the
way we performed the prognostic analysis. Indeed, Sharir
et al. (34,35) censored patients revascularized within 60 d
of nuclear testing. However, when we censored revascular-
ized patients the number of events was small, and SRS was
the only final independent predictor of cardiac events.
Furthermore, we combined the 2 endpoints cardiac death
and nonfatal MI. Finally, enrolling patients who had
undergone coronary arteriography might have selected a
patient population at higher risk than in previous studies, in
which patients were enrolled mainly on the basis of
symptoms and the pretest probability of IHD.
Gated SPECT and Coronary Anatomy
The greater diagnostic accuracy of stress-induced myo-
cardial perfusion abnormalities over electrocardiographic
signs of ischemia and greater contribution of nuclear
imaging to risk stratification are widely acknowledged. It
is also well known that myocardial perfusion imaging is
superior to coronary arteriography in risk stratification of
patients with IHD. In 1992, Pollock et al. demonstrated that
myocardial perfusion is superior to coronary arteriography
in risk stratification of IHD patients (4); at variance with
our study, these authors used 201Tl and static planar imag-
ing, and all the patients had suspected IHD. In a series of
316 patients, Iskandrian et al. (5) showed the independent
and incremental prognostic information of exercise SPECT
thallium imaging even when catheterization data are avail-
able; unlike us, these authors studied patients with definite
coronary artery disease who were medically treated. In
addition, in none of the above studies were laboratory
variables and echocardiography considered. This study
largely confirms the advantages of perfusion imaging over
clinical, electrocardiographic, laboratory, and resting echo-
cardiographic data and shows the incremental prognostic
value of gated SPECT information over angiographic data.
Thus, the severity and extent of stress-induced myocardial
perfusion abnormalities provide a better prognostic strati-
fication than does the severity of coronary artery disease,
using both a 50% and a 70% stenosis threshold and taking
into account the proximality of the lesions along the
coronary tree. This observation should suggest a wider
use of myocardial perfusion imaging in risk stratification of
patients with known or suspected IHD.
Gated SPECT and Laboratory Examinations
In previous myocardial perfusion imaging studies, the
prognostic value of several laboratory tests has received
FIGURE 3. Prognostic value during diagnostic work-up
when information provided by gated SPECT is available after
coronary arteriography.
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little attention. Chronic kidney disease is known to be an
important risk factor for atherosclerosis. In the setting of
chronic kidney disease, myocardial perfusion abnormalities
are common (13). However, most radionuclide imaging
studies have examined populations with end-stage renal
failure. Whether mild forms of renal dysfunction are as-
sociated with IHD among patients with positive myocardial
perfusion imaging has not been investigated previously.
This study shows the prognostic impact of even mild
increments in creatinine levels.
In cardiac patients, a low triiodothyronine syndrome has
been related to a poor outcome (14), and a mildly altered
thyroid status has been associated with an increased risk of
mortality (14). More recently, thyrotropin levels within the
reference range were positively and linearly associated with
IHD mortality (36). In our study, thyroid status was not able
to predict event-free survival, probably because of the
relatively small sample size and because of the inclusion
of several patients without heart failure.
In previous studies, HDL cholesterol level was a signif-
icant inverse predictor of subsequent major cardiovascular
events (15,16). When the LDL cholesterol level achieved in
patients receiving therapy was considered, the role of HDL
cholesterol was less marked, though still of borderline
significance. The relationship remained significant even in
patients whose LDL cholesterol level was less than 70 mg/
dL (16). Our study shows a negative incremental prognostic
value for a reduction in the ratio between LDL and HDL
cholesterol levels. Finally, we did not find any prognostic
impact of C-reactive protein, likely because of the selection
of patients in the chronic phase of IHD.
Study Limitations
A limitation of this study is the selection of patients who
have an intermediate pretest probability of coronary artery
disease and thus do not reflect the general population of
subjects undergoing gated SPECT for known or suspected
IHD. More likely enrolled patients—though stable—reflect
a higher-risk population, as indirectly shown by the high
prevalence of previous MI (43%) and the main cardiovas-
cular risk factors and by the fact that all enrolled patients
underwent coronary arteriography. Another limitation is
related to the small patient cohort, which does not allow an
in-depth evaluation of the potential benefits of treatment.
A mandatory clarification concerns the difference between
prognostic and diagnostic impact. Specifically, our consid-
erations on myocardial perfusion imaging are limited to the
prognostic stratification; we were aware that several varia-
bles that did not enter into our prediction model (such as
coronary arteriography) carry clinically significant informa-
tion in terms of diagnosis and therapeutic decision making.
In clinical practice, stress echocardiography is widely
used for risk stratification of patients with IHD. Stress
echocardiography was not performed in this study because
patients were selected on the basis of having undergone
gated SPECT. Finally, the values of cardiac peptides were
not available for the entire patient population and were not
considered among the tested predictors.
CONCLUSION
In a population of patients with known or suspected IHD,
gated SPECT appeared to be the best predictor of cardiac
event–free survival, considering all the main variables
derived from the diagnostic work-up. In particular, the
extent of scar tissue predicted event-free survival better
than did LVEF, and stress-induced myocardial perfusion
abnormalities predicted event-free survival better than did
coronary arteriography. Laboratory variables such as serum
creatinine and LDL/HDL cholesterol levels were indepen-
dent predictors of event-free survival but were less power-
ful than SRS and SDS.
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